Vikas Dharnidharka, Michael Green, Steven Webber, Ralf Ulrich Trappe (Hg.): Post-Transplant Lymphoproliferative Disorders. 2. Auflage 2021 (Springer)
DOI: 10.1007/978-3-030-65403-0

Trappe RU, Dierickx D, Zimmermann H, et al. Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial. J Clin Oncol. 2017;35(5):536-543.